Dr. Gauri C. Bedi, MD

Dr. Bedi practices at Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center.

Dr. Bedi's NPI, 1275574048, was assigned on June 10, 2006. Dr. Bedi holds Maryland license D0045264.

Dr. Bedi's primary practice is Mercy Medical Center, at 301 Saint Paul Place, Baltimore, MD 21202 in Baltimore City. The practice phone is (410) 332-9237.

Dr. Bedi's primary practice is Mercy Medical Center in Baltimore, Maryland, part of Mercy Medical Center. The medical group on file is Mercy Personal Physicians Downtown. Dmand AI also links Dr. Bedi to 1 more group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bedi practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Bedi's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Bedi is licensed in Maryland.

CMS data shows 192 Medicare services from Dr. Bedi across 6 procedure codes in 2024, for 141 Medicare patients. Medicare paid $14,969 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 141 Medicare patients who saw Dr. Bedi in 2026. The largest group is 65 to 74, with 79 patients. 75% of them have cancer, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bedi's median patient age at 69, with 100% women.

In 2026, Dr. Bedi wrote 35 Medicare Part D claims for 16 patients. 94% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $238 in total drug cost. In 2017, CMS named 19 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Bedi for performance year 2026, reported as part of a group. Dr. Bedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of mastectomy by Dr. Bedi, more than 91% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Bedi, published from 2016 to 2024. Dr. Bedi's most frequent co-authors are Neil B. Friedman, MD, Shawna C. Willey, MD and Andrea Marie Abbott, MD.

Dmand AI links Dr. Bedi to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 14 general payments to Dr. Bedi from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $269.